dehydroepiandrosterone sulfate has been researched along with medroxyprogesterone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Sasagawa, I; Satomi, S | 1 |
| Schmidt, NA; Thijssen, JH; Trienekens, PH | 1 |
| Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE | 1 |
| Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N | 1 |
| Ciesielska-Kopacz, N; Kajdaniuk, D; Kos-Kudła, B; Kudła, M; Marek, B; Ostrowska, Z | 1 |
6 other study(ies) available for dehydroepiandrosterone sulfate and medroxyprogesterone
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer.
Topics: Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Follicle Stimulating Hormone; Gonadotropins; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Palliative Care; Prolactin; Prostatic Neoplasms; Thyrotropin | 1990 |
The effect of age, weight-related parameters and hormonal contraceptives on andrological assays.
Topics: Age Factors; Body Weight; Contraceptives, Oral, Hormonal; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Reference Values; Sex Hormone-Binding Globulin; Testosterone | 1986 |
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Sex Hormone-Binding Globulin; Testosterone | 1987 |
Inhibition of steroid sulfatase activity by danazol.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen | 1984 |
Effects of hormone replacement therapy on endocrine and spirometric parameters in asthmatic postmenopausal women.
Topics: Administration, Cutaneous; Asthma; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Female; Hormone Replacement Therapy; Humans; Hydrocortisone; Medroxyprogesterone; Menopause; Middle Aged; Spirometry | 2001 |